News from aratana therapeutics A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Jul 02, 2014, 07:30 ET

Aratana Therapeutics Files for USDA Product License of AT-014 Canine Osteosarcoma Immunotherapy

 Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on licensing, developing and commercializing innovative...

Jun 23, 2014, 16:01 ET

Aratana Therapeutics Adds Robert P. Roche, Jr. to Board of Directors

 Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing, development and commercialization of...

Jun 19, 2014, 16:31 ET

Aratana Therapeutics to Participate in Two Upcoming Investor Conferences

 Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on licensing, developing and commercializing innovative...

Jun 18, 2014, 16:15 ET

Aratana Therapeutics Initiates and Doses First Patient in Market Development Studies of AT-005 for Treating Canine T-cell Lymphoma

KANSAS CITY, Kan., June 18, 2014 /PRNewswire/ -- Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on...

Jun 12, 2014, 18:45 ET

Aratana Therapeutics Expands Pain Franchise with Novel Regenerative Cell Therapy for Treating Osteoarthritis

 Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on licensing, developing and commercializing innovative...

Jun 09, 2014, 08:09 ET

Aratana Therapeutics Presents Safety and Clinical Findings at 2014 ACVIM Forum

Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on licensing, developing and commercializing innovative...

May 30, 2014, 08:14 ET

Aratana Therapeutics to Participate in Upcoming Investor Conferences

 Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on licensing, developing and commercializing innovative...

May 23, 2014, 09:56 ET

Aratana Therapeutics to Participate in Two Upcoming Investor Conferences

Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on licensing, developing and commercializing innovative...

May 13, 2014, 16:01 ET

Aratana Therapeutics Reports First Quarter 2014 Results

 Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on licensing, developing and commercializing innovative...

May 12, 2014, 07:30 ET

Aratana Therapeutics Initiates Pivotal Study for AT-001

 Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing, development and commercialization of...

May 05, 2014, 07:30 ET

Aratana Therapeutics Inc. to Report First Quarter Financial Results

Aratana Therapeutics, Inc. (Nasdaq: PETX), a pet therapeutics company focused on the licensing, development and commercialization of innovative...

May 02, 2014, 07:30 ET

Aratana Therapeutics to Present at 2014 ACVIM Forum

 Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing, development and commercialization of...

Mar 27, 2014, 07:30 ET

Aratana Therapeutics Adds David Brinkley to Board of Directors

 Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing, development and commercialization of...

Mar 19, 2014, 20:01 ET

Aratana and Advaxis Enter Exclusive Global Licensing Agreement

 Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing, development and commercialization of...

Mar 13, 2014, 07:30 ET

Aratana Therapeutics Reports Fourth Quarter and Full Year 2013 Results

 Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on licensing, developing and commercializing innovative...

Mar 11, 2014, 20:59 ET

Aratana Therapeutics to Report Fourth Quarter and Full Year 2013 Financial Results

 Aratana Therapeutics, Inc. (Nasdaq: PETX), a pet therapeutics company focused on the licensing or acquisition, development and...

Mar 06, 2014, 17:12 ET

Aratana Therapeutics to Present at Two Upcoming Investor Conferences

 Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing or acquisition, development and...

Feb 05, 2014, 16:10 ET

Aratana Therapeutics Announces Additions to Board of Directors

 Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing or acquisition, development and...

Jan 29, 2014, 19:16 ET

Aratana Therapeutics Announces Full Exercise of Underwriters' Option to Purchase Additional Shares

Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing or acquisition, development and commercialization of...

Jan 29, 2014, 08:52 ET

Aratana Therapeutics, Inc. Announces Upsizing and Pricing of Public Offering

 Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing or acquisition, development and...

Organizations in the News

The organizations with the most activity in PR Newswire's News Room

ReportBuyer
Research and Markets
Investor-Edge